Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Pilot Implementation Trial of Implementation Toolkits for Diabetes Coaching

26 agosto 2026 aggiornato da: Julia Price, Nemours Children's Clinic

Single Site Implementation Pilot Trial of Base, Enhanced, and Sustainment Implementation Toolkits for Diabetes Coaching for Families With an Adolescent With Type 1 Diabetes

The goal of this study is to learn if toolkits of implementation strategies (e.g., provider and staff education, clear plan for how to refer and bill) help pediatric type 1 diabetes medical and psychology providers deliver a behavioral intervention (Diabetes Coaching) to more families. The main questions this study aims to answer are:

  • Is it possible to put these toolkits of implementation strategies into place in one pediatric hospital?
  • Do providers and staff find these toolkits of implementation strategies acceptable?

Participants will be type 1 diabetes professionals (endocrinologists, nurse practitioners, psychologists, scheduling and billing staff) at Nemours Children's Hospital Delaware. Participants will:

  • Attend educational and/or planning meetings
  • Receive email updates on referral data
  • Complete surveys
  • Complete an interview

Panoramica dello studio

Descrizione dettagliata

Type 1 diabetes (T1D), one of the most prevalent chronic pediatric diseases in the United States, requires a complex treatment regimen. Youth with T1D, particularly adolescents, more frequently have higher glycemic levels. Less than 30% of youth achieve the recommended level of glycemic control. Compared to adults, youth are more at-risk for related complications (diabetic ketoacidosis) that can lead to heart disease, diabetic coma, and death. These complications often result from challenges completing T1D care tasks. Evidence-based behavioral interventions can increase T1D care task completion and lower glycemic levels (i.e., A1c). Integrating these interventions into standard T1D care may lead to better overall health for this population. Implementation science offers theory and rigorous methods to accomplish this goal, but few studies have employed them.

Behavioral Family Systems Therapy-Diabetes (BFST-D) is efficacious for increasing T1D care task completion and lowering A1c, particularly among adolescents who have higher glycemic levels (A1c≥9.0%). A brief 4-session, adapted version of BFST-D (Diabetes Coaching) delivered as part of standard care was associated with lowered glycemic levels. Despite these efficacy and initial effectiveness data, few receive this evidence-based care. Although Diabetes Coaching has been offered at the PI's institution, less than 10% of patients received it. Evaluation of strategies to improve reach of Diabetes Coaching in standard care is needed.

In a large national qualitative study of key informants (adolescents with T1D-caregiver dyads, medical and psychosocial healthcare providers, healthcare leaders) drawn from 5 children's hospitals, the PI identified determinants of implementing Diabetes Coaching (K23 Aim 1). Factors influencing implementation ranged across all domains of the Consolidated Framework for Implementation Research (CFIR), including those related to family needs and opportunity to engage in this care (evening, telehealth delivery, expert providers who are empathic, patient, encouraging, referrals from trusted provider when A1c rising, evidence of improved A1c), provider knowledge and self-efficacy in referring to and delivering Diabetes Coaching, and clinic resources (lack of streamlined referral processes; leadership buy-in), as well as external factors (insurance coverage).

Using these rich data and an evidence-based quality improvement (EBQI) approach with iterative feedback from Family and Healthcare Professional Diabetes Care Advisory Boards (F-DCAB; P-DCAB) drawn from Nemours Children's Hospital Delaware (NCHD), the PI developed a toolkit of implementation strategies (K23 Aim 2). Implementation strategies are methods for integrating evidence-based practices into standard care.20 Critical strategies needed to integrate Diabetes Coaching into standard T1D care at NCHD emerged and comprise a Base Implementation Toolkit (BIT). Pre-implementation BIT strategies include provider and staff education meetings (e.g., referring and delivering Diabetes Coaching), identification of and training of Champions for implementation, materials to increase demand for Diabetes Coaching among families (e.g., family-facing educational materials), and development of a workflow blueprint and of tools to monitor implementation. Active implementation BIT implementation strategies include feedback loop to clinical provider team regarding summary level data on uptake of referrals to and family engagement in Diabetes Coaching, as well as consultation to support problem-solving workflow and other implementation challenges with Champions. Two strategies (audit and feedback, adapting delivery format and timing of Diabetes Coaching) may be added to BIT (BIT-Enhanced) to improve adoption among medical providers with lower referral rates and/or to increase reach if few families attend Diabetes Coaching. BIT-Enhanced requires additional time and resources (e.g., Champion and providers review individual data, collaborate on ways to increase referrals). Thus, examining if this additional strategy meaningfully improves outcomes offers critical data for maintaining only the strategies that are necessary and sufficient. Key to maintaining implementation of any evidence-based practice, including Diabetes Coaching, is considering sustainability early on. The primary sustainability strategy involves training the Champions early and planful progression of their role in the implementation efforts, from first attending the PI-led (implementation and content expert) brief consultation meetings and data tracking to then independently leading these meetings (BIT-Sustainment)

Guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) and the Reach, Efficacy, Adoption, Implementation, Maintenance (RE-AIM) frameworks, the goals of the current single site pilot implementation feasibility trial (K23 Aim 3) are to pilot study procedures and the implementation toolkits and track effectiveness of implementation toolkits in preparation for a fully powered trial. The overarching aim of this study is to gather preliminary data to support an R01 application to conduct a large, multi-site randomized hybrid implementation-effectiveness trial testing uptake of Diabetes Coaching and tracking patient health outcomes.

Aim 1 (Feasibility & Acceptability): Conduct a pilot implementation feasibility study at the PIs institution (NCHD) to examine acceptability and feasibility of BIT for Diabetes Coaching and BIT-Enhanced for providers with lower adoption rates (<80%) and with low reach (<5 families per group), and BIT-Sustainment. In addition, study procedures will be piloted in preparation for a fully powered trial.

Aim 2 (Implementation Outcomes): Examine four exploratory implementation outcomes, (1) medical provider adoption of referring to Diabetes Coaching (i.e., number of providers vs. number of providers referring >80% eligible families), (2) psychologist fidelity in delivering Diabetes Coaching, and (3) reach of Diabetes Coaching to the target patient population (i.e., number families eligible vs. referred, number of sessions attended, completion rate). (4) Sustainability of adoption, reach, and fidelity will be examined following the removal of most research resources.

Tipo di studio

Interventistico

Iscrizione (Stimato)

15

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

    • Delaware
      • Wilmington, Delaware, Stati Uniti, 19803
        • Reclutamento
        • Nemours Children's Hospital - Delaware
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  1. Involved in the direct clinical medical care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  2. Involved in the direct clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  3. Involved in the scheduling and/or insurance coverage verification in the clinical psychological care of adolescents with T1D at Nemours Children's Hospital - Delaware OR
  4. Holds a leadership role in Endocrinology and/or Behavioral Health at Nemours Children's Hospital - Delaware

Exclusion Criteria:

1. Not involved in the direct clinical care or administrative parts of care of families with an adolescent with T1D at Nemours Children's Hospital - Delaware

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Implementation Toolkit
In this arm, all participants will receive BIT. If indicated, BIT-Enhanced will be deployed. All participants will receive BIT-Sustainment.
The Base Implementation Toolkit (BIT) includes strategies across pre-implementation, active implementation, and sustainment phases. Pre-implementation BIT strategies include provider and staff education meetings (e.g., meetings introducing processes for referring and delivering Diabetes Coaching), identification of and training the psychology providers and one medical provider as Champions for implementation and deliverer of Diabetes Coaching (psychology providers only), materials to increase demand for Diabetes Coaching among families (e.g., family-facing educational materials), and development of a workflow blueprint and of tools to monitor implementation. Active implementation BIT strategies include reporting summary level data on uptake of referrals to and family engagement in Diabetes Coaching to clinical type 1 diabetes providers, as well as facilitation (i.e., consultation) to support problem-solving workflow and other implementation challenges.
Altri nomi:
  • BIT-Enhanced
  • BIT-Sustainment
During active implementation, two strategies (audit and feedback, adapting delivery format and timing of Diabetes Coaching) may be added to BIT (BIT-Enhanced) to improve adoption among medical providers with lower referral rates (adoption rate <80%) and/or to increase reach if few families schedule and attend Diabetes Coaching (<6 families scheduled per group and/or <4 families attend group). BIT-Enhanced requires additional time and resources (e.g., Champions and providers review individual data, collaborate on ways to increase referrals). Thus, examining if these additional strategies meaningfully improve outcomes offers critical data for maintaining only the strategies that are necessary and sufficient for adoption, reach, and fidelity outcomes.
Key to maintaining implementation of any evidence-based practice, including Diabetes Coaching, is considering sustainability early on. The primary sustainability strategy (BIT-Sustainment) involves training multiple Champions early and planful progression of their role in the implementation efforts, from first participating in PI-led (implementation and content expert) consultation huddles and shadowing data tracking to then independently leading these huddles, reporting adoption data, and, for those requiring BIT-Enhanced, employing audit and feedback and reach data as needed. The BIT-Sustainment will be deployed for all providers (BIT and BITE) during the sustainment phase of implementation.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility of Implementation Strategies
Lasso di tempo: Post-completion of Sustainment implementation strategies; 10 months
Total score on the Feasibility of Intervention Measure (FIM) for each implementation strategy. The FIM is a validated, brief, 4-item, survey on the feasibility of implementation strategies. Each item is rated on a 5-point Likert scale, from completely disagree (1) to completely agree (5), with higher scores indicating greater feasibility.
Post-completion of Sustainment implementation strategies; 10 months
Acceptability of Implementation Strategies
Lasso di tempo: Post-completion of Sustainment implementation strategies (10 months)
Total score on the Acceptability of Intervention Measure (FIM) for each implementation strategy. The AIM is a validated, brief, 4-item, survey on the feasibility of implementation strategies. Each item is rated on a 5-point Likert scale, from completely disagree (1) to completely agree (5), with higher scores indicating greater acceptability.
Post-completion of Sustainment implementation strategies (10 months)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Adoption of Referral Practices
Lasso di tempo: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percentage of providers who reach adoption (total number of medical providers vs. number of medical providers referring >80% of eligible families per week) measured via electronic health record data.
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Reach of Diabetes Coaching
Lasso di tempo: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percent of eligible families completing at least 3 of 4 Diabetes Coaching sessions versus total number of eligible families (based on electronic health record data).
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Fidelity of Delivering Diabetes Coaching
Lasso di tempo: Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)
Percent of completed items on self-report checklists for delivering Diabetes Coaching sessions, as reported by psychology provider.
Post-Active Implementation Phase (6 months); Post-Sustainment Phase (10 months)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

26 agosto 2026

Completamento primario (Stimato)

30 aprile 2027

Completamento dello studio (Stimato)

30 aprile 2027

Date di iscrizione allo studio

Primo inviato

5 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 agosto 2026

Primo Inserito (Effettivo)

17 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

27 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

26 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

De-identified questionnaire responses will be shared. De-identified qualitative data from semi-structured interviews may be shared under a data use agreement. Recordings of qualitative interviews will not be shared publicly due to the potential of voice identification of participants. Original data will be maintained on a secure drive at Nemours Children's Hospital, Delaware. Metadata that will be made accessible to facilitate interpretation of scientific data include study protocols, consent forms, interview scripts, codebooks, questionnaires, data dictionaries, analysis codes, and other supporting documentation. The data dictionaries will define and describe all variables in the dataset.

Periodo di condivisione IPD

Beginning 3 months after the publication of results with no end date.

Criteri di accesso alla condivisione IPD

Investigators who have interest in the data for research purposes may access the IPD and supporting information. De-identified questionnaire responses will be shared. De-identified qualitative data from semi-structured interviews may be shared under a data use agreement. Recordings of qualitative interviews will not be shared publicly due to the potential of voice identification of participants. Original data will be maintained on a secure drive at Nemours Children's Hospital, Delaware. Metadata that will be made accessible to facilitate interpretation of scientific data include study protocols, consent forms, interview scripts, codebooks, questionnaires, data dictionaries, analysis codes, and other supporting documentation. The data dictionaries will define and describe all variables in the dataset. De-identified data will be available through openICPSR.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi